Amorim Fábio Jorge Ramalho de, Valença-Feitosa Fernanda, Rios Marcos Cardoso, Santos Souza Carlos Adriano, Barros Izadora Menezes da Cunha, Oliveira-Filho Alfredo Dias de, Lyra-Júnior Divaldo Pereira de
Pharmacy Department, Laboratory of Teaching and Research in Social Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil.
University Center AGES, Paripiranga, Brazil.
JMIR Res Protoc. 2023 Apr 21;12:e35865. doi: 10.2196/35865.
The clinical activities developed by pharmacists in a hospital environment can improve health outcomes and generate savings for hospitals. However, to determine whether pharmaceutical interventions are cost effective, it is essential to define a method according to which cost-effectiveness is intended to be measured. In addition, the quality of economic assessments and the amount of information present in systematic reviews in the literature make it difficult to analyze the effects of this intervention.
This paper aims to provide an overview of systematic reviews on the pharmacoeconomic impact of the performance of pharmaceutical care in hospitals.
A systematic search of the Cochrane Library databases, PubMed or MEDLINE, LILACS, Scopus, Web of Science, Google Scholar, and Open Thesis will be performed using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. The search will involve the use of keywords determined using the Medical Subject Headings database to define the search terms and include the following terms: "pharmacoeconomics," "pharmaceutical care," and "hospital." The study designs to be included will be systematic reviews of good quality. Studies will be included that address pharmacoeconomics; studies that evaluated pharmaceutical care in hospitals; and studies published in Portuguese, English, or Spanish. The primary outcome sought in the systematic reviews will be the cost ratio in monetary units and the outcomes in monetary or natural units. The secondary economic outcomes considered will be determined based on factors associated with the drugs and translated into benefit, efficacy, or utility.
It is intended to start this overview in January 2023. Thus far, only previous searches have been carried out to contextualize the theme and build the protocol.
This overview will determine the pharmacoeconomic impact of pharmaceutical care interventions in the hospital environment. In addition, this study will point out which clinical outcomes in natural units are impacted by the performance of pharmaceutical care and the strengths and limitations of each approach. It will also identify gaps in the literature and areas for future work.
PROSPERO CRD42019140665; https://tinyurl.com/bddwnz43.
药剂师在医院环境中开展的临床活动可改善健康结局并为医院节省开支。然而,要确定药物干预措施是否具有成本效益,必须定义一种用于衡量成本效益的方法。此外,经济评估的质量以及文献系统评价中所包含信息的数量使得分析这种干预措施的效果变得困难。
本文旨在概述关于医院药学服务绩效的药物经济学影响的系统评价。
将使用PRISMA(系统评价和Meta分析的首选报告项目)声明对Cochrane图书馆数据库、PubMed或MEDLINE、LILACS、Scopus、Web of Science、谷歌学术和开放论文进行系统检索。检索将涉及使用医学主题词数据库确定的关键词来定义检索词,并包括以下术语:“药物经济学”、“药学服务”和“医院”。纳入的研究设计将是高质量的系统评价。将纳入涉及药物经济学的研究;评估医院药学服务的研究;以及以葡萄牙语、英语或西班牙语发表的研究。系统评价中寻求的主要结局将是以货币单位表示的成本比率以及以货币或自然单位表示的结局。所考虑的次要经济结局将根据与药物相关的因素来确定,并转化为效益、疗效或效用。
计划于2023年1月开始进行此概述。到目前为止,仅进行了先前的检索以将该主题置于背景中并制定方案。
此概述将确定医院环境中药学服务干预措施的药物经济学影响。此外,本研究将指出以自然单位表示的哪些临床结局受到药学服务绩效的影响以及每种方法的优势和局限性。它还将识别文献中的空白以及未来工作的领域。
PROSPERO CRD42019140665;https://tinyurl.com/bddwnz43